News Releases Keyword Search Year None20232022202120202019 Date Title 03/07/23 Optinose Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Highlights 02/28/23 Optinose Announces Reporting Date for Fourth Quarter 2022 Financial Results 02/21/23 Optinose Submits Supplemental New Drug Application for XHANCE Label Expansion 01/31/23 Optinose Announces CEO Transition and Business Update